Clinical Trial: SWOG MM1OA-S03

SWOG MM1OA-S03

Status: New, Open

A Randomized Phase II Trial of ASTX727 and Venetoclax Compared with ASTX727, Venetoclax, and Enasidenib for Newly Diagnosed Older Adults with IDH2 Mutant Acute Myeloid Leukemia: A MyeloMATCH Substudy

(See required screening study MYELOMATCH)